Disorders arising from impaired assembly of succinate dehydrogenase (SDH) result in a myriad of pathologies, consistent with its unique role in linking the citric acid cycle and electron transport chain. In spite of this critical function, however, only a few factors are known to be required for SDH assembly and function. We show here that two factors, Sdh6 (SDHAF1) and Sdh7 (SDHAF3), mediate maturation of the FeS cluster SDH subunit (Sdh2/SDHB). Yeast and Drosophila lacking SDHAF3 are impaired in SDH activity with reduced levels of Sdh2. Drosophila lacking the Sdh7 ortholog SDHAF3 are hypersensitive to oxidative stress and exhibit muscular and neuronal dysfunction. Yeast studies revealed that Sdh6 and Sdh7 act together to promote Sdh2 maturation by binding to a Sdh1/Sdh2 intermediate, protecting it from the deleterious effects of oxidants. These studies in yeast and Drosophila raise the possibility that SDHAF3 mutations may be associated with idiopathic SDH-associated diseases.
INTRODUCTION
Succinate dehydrogenase (SDH) is an integral component of both the mitochondrial respiratory chain and the tricarboxylic acid (TCA) cycle. It catalyzes the two-electron oxidation of succinate to fumarate with the reduction of ubiquinone to ubiquinol (succinate:ubiquinone oxidoreductase). SDH is embedded within the inner membrane (IM) of mitochondria and consists of four nuclear-encoded subunits, designated Sdh1 through Sdh4 in yeast and SDHA through SDHD in mammalian cells. SDH deficiency in humans results in infant encephalomyopathy, myopathy, or tumorigenesis in the adult (Finsterer, 2008; Rustin and Rö tig, 2002) . Loss-of-function mutations in human genes for SDHA, SDHB, SDHC, and SDHD are strongly linked with susceptibility to familial paraganglioma, pheochromocytoma, gastrointestinal stromal tumors, and renal cell carcinoma (Bardella et al., 2011; Baysal et al., 2000; Feichtinger et al., 2010; Janeway et al., 2011) . Tumorigenesis arising from SDH deficiency is purportedly related to the deleterious effects of supraphysiological levels of succinate, which is a known inhibitor of a myriad of a-ketoglutarate (aKG)-dependent enzymes, including prolyl hydroxylases, histone, and DNA demethylases (Selak et al., 2005; Xiao et al., 2012) .
This tetrameric enzyme contains five redox cofactors, including a covalently bound FAD and three iron-sulfur (FeS) clusters in a hydrophilic segment consisting of two subunits (Sdh1 and Sdh2) and a heme-containing membrane anchor domain consisting of Sdh3 and Sdh4 subunits (Robinson and Lemire, 1996) . The FeS clusters facilitate electron transfer to the ubiquinone-binding site formed between Sdh2 and the membrane subunits (Sun et al., 2005) .
Assembly factors are often used to facilitate cofactor insertion in mitochondrial respiratory complexes and mitigate unwanted reactions during biogenesis. Recently, two SDH assembly factors associated with human pathogenesis were identified. Succinate dehydrogenase assembly factor 1 (SDHAF1) was found in a study of infantile mitochondrial diseases in which two families had multiple children afflicted with leukoencephalopathy (Ghezzi et al., 2009) . Biochemical analyses revealed a SDH deficiency in muscle samples and fibroblasts from these patients along with missense mutations in SDHAF1. Deletion of the yeast ortholog of SDHAF1 (SDH6) resulted in a respiratory deficiency and a specific reduction in SDH activity (Ghezzi et al., 2009) . SDH deficiency has subsequently been reported in other patients that carry SDHAF1 mutations . Succinate dehydrogenase assembly factor 2 (SDHAF2 or yeast Sdh5) was shown to be required for the covalent attachment of FAD to the catalytic SDHA (Sdh1) subunit (Hao et al., 2009) . Yeast lacking Sdh5 were respiratory deficient due to an absence of SDH activity. Germline loss-of-function mutations in SDHAF2 
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Maturation of the FeS Subunit of SDH were identified in SDH-deficient neuroendocrine paraganglioma tumors (Hao et al., 2009) . A number of SDH-deficient pathologies, including Leigh syndrome, gastrointestinal stromal tumors, and neuroblastomas, have also been reported that lack mutations in known SDH assembly factors or SDH structural subunits (Feichtinger et al., 2010; Janeway et al., 2011) . Thus, additional SDH assembly factors may remain to be discovered, potentially providing insights into the causes of idiopathic SDH-associated diseases.
Sdh6 is a member of the LYR protein family that consists of ten proteins in the human proteome and four in the yeast proteome ( Figure 1A ). Within yeast, the founding member is the mitochondrial Isd11 protein that functions in the matrix FeS biogenesis pathway as an effector of the Nfs1 cysteine desulfurase (Adam et al., 2006; Wiedemann et al., 2006) . We demonstrated that a second LYR protein Mzm1 is a chaperone for the Rieske FeS subunit of complex III (Atkinson et al., 2011; Cui et al., 2012) . The remaining yeast LYR proteins are Sdh6 and Acn9 (human ortholog ACN9). Although Sdh6 is required for proper SDH activity, its molecular mechanism remains unknown. Moreover, Acn9 (designated Sdh7 in yeast and SDHAF3 in humans and flies) has no known function. Here we show that these two factors are required for SDH biogenesis in eukaryotes. Both Sdh6 and Sdh7 protect Sdh2 maturation from the deleterious effects of endogenous reactive oxygen species. We also report that loss of SDHAF3 in Drosophila cells leads to a marked SDH deficiency analogous to that in yeast, with defects in muscular and neuronal function in mutant flies. This study identifies functions of two SDH assembly factors, providing a more complete understanding of its critical role in cellular energy production and a potential molecular framework for defining currently idiopathic SDH-associated diseases.
RESULTS

Cells Lacking Sdh6 and Sdh7 Exhibit SDH Deficiency
As a first step toward characterizing Sdh6 and Sdh7 function, we examined the growth phenotypes of sdh6D or sdh7D mutants on nonfermentable carbon sources using S. cerevisiae. Compared to wild-type cells, cells lacking Sdh6 or Sdh7 exhibited a partial growth defect on glycerol/lactate medium and a severe growth defect on acetate medium ( Figure 1B) , which is consistent with previous studies (Ghezzi et al., 2009; McCammon, 1996) . We confirmed that the respiratory growth defects of sdh6D and sdh7D mutants were attributed to deletions of SDH6 and SDH7, as respiratory growth of sdh6D and sdh7D cells was restored with epitope-tagged Sdh6 and Sdh7, respectively ( Figure S1A , available online). Since both Sdh6 and Sdh7 belong to the LYR motif protein family ( Figure 1A ), we looked for genetic interactions between their encoded proteins. The sdh6D sdh7D double-deletion strain exhibited a marked synthetic growth defect on glycerol/lactate medium ( Figure 1B ). In addition, the overexpression of SDH6 partially suppressed the respiratory growth defect of sdh7D cells ( Figure 1C) ; however, overexpression of SDH7 failed to restore respiratory function of sdh6D cells.
Metabolomic profiling was used to identify the biological process impaired in sdh6D and sdh7D mutants, assaying the levels of approximately 100 polar metabolites. We cultured cells in synthetic minimal medium with 2% raffinose and 0.2% glucose to stationary phase. Metabolites extracted from cells were analyzed using gas chromatography-mass spectrometry (GC-MS) ( Figure 1D ). Cells lacking either Sdh6 or Sdh7 exhibited elevated succinate levels and attenuated fumarate and malate levels, consistent with impaired conversion of succinate to fumarate by SDH in the citric acid cycle. These observations in sdh6D cells are consistent with the previous study in fibroblasts harboring a mutated SDHAF1 gene (Ghezzi et al., 2009) . Moreover, the sdh6D sdh7D double mutant showed an enhanced accumulation in succinate, consistent with the synergistic respiratory growth defects in these cells.
To confirm that the increased succinate/fumarate ratio in sdh7D mutants was due to impaired SDH function, we quantified SDH activity in mitochondria purified from wild-type (WT) and mutant cells lacking Sdh6 or Sdh7. Mitochondria isolated from sdh6D and sdh7D cells harvested at mid-log phase exhibited modest diminutions of SDH activity, but the deficit was magnified in stationary-phase cells ( Figure 1E ). The sdh6D sdh7D double mutant showed markedly decreased SDH activity in mid-log cultures (34% of WT; Figure S1B ) relative to the single mutants, in accordance with the synergistic respiratory growth defect and TCA cycle intermediates in sdh6D sdh7D double mutants. Enzymatic activities of pyruvate dehydrogenase, a-ketoglutarate dehydrogenase, aconitase, malate dehydrogenase, and bc 1 complex III were unaffected in cells lacking Sdh6 or Sdh7 (Figures S1B and S1C) .
A moderate diminution of the assembled tetrameric SDH complex was seen in mitochondria isolated from late-log cultures of sdh6D or sdh7D mutants as visualized by blue native (BN)-PAGE ( Figure 1F ). The abundance of the SDH complex was further (Adam et al., 2006) ; Mzm1, a protein facilitating the Rieske FeS protein insertion into bc 1 (Cui et al., 2012) ; Sdh6 (SDHAF1); and Sdh7. (B) Serial dilutions (10-fold) of cells starting from optical density 600 (OD 600 ) = 0.5 were spotted on synthetic complete (SC) media containing different carbon sources, as indicated, and incubated at 30 C.
(C) Serial dilutions (10-fold) of cells were spotted on SC media lacking uracil and incubated at 30 C. EV, empty vector.
(D) Metabolites extracted from cells cultured in synthetic minimal media containing 2% raffinose/0.2% glucose were analyzed using GC-MS. Cells were harvested at OD 600 = 2. Relative levels of metabolites to WT are represented as mean ± SEM (n R 4 biological replicates; *p < 0.05; **p < 0.005).
(E) Relative SDH activity in isolated mitochondria compared to WT. Mitochondria were isolated from cells grown in SC media plus 2% raffinose/0.2% glucose for 24 hr (mid-log) and 48 hr (stationary). Data are shown as mean ± SD (n = 3; **p < 0.05). Figures 1F  and S2 ). Therefore, Sdh6 and Sdh7 appear to function in SDH assembly rather than in the regulation of SDH activity.
Maturation of Sdh2 Is Impaired in the Absence of Sdh6 or Sdh7
To characterize the roles of Sdh6 and Sdh7, the steady-state levels of SDH subunits were quantified in mitochondria isolated from mutant cells. The levels of Sdh2 were attenuated in both sdh6D and sdh7D mutants and further diminished in the sdh6D sdh7D double mutant ( Figure 2A ). In contrast, Sdh1 levels were unchanged in the mutant cells, and covalent flavinylation of Sdh1 was not significantly altered ( Figure 2A ). Cells lacking Sdh5 are compromised in Sdh1 flavinylation, leading to a reduced stability of Sdh1 (Hao et al., 2009; Kim et al., 2012) . A mitochondrial in vitro protein import assay was used to address a role for Sdh6 and Sdh7 in Sdh2 maturation. The import assay consisted of the in vitro import of 35 S-methionine-labeled Sdh2 into purified mitochondria isolated from sdh2D cells. Sdh2-deficient mitochondria were used to ensure that a pool of unassociated Sdh1 would be available for a stabilizing interaction with imported Sdh2. Furthermore, the use of sdh2D cells negates any changes in the mitochondrial membrane potential (which drives protein import) by the loss of Sdh6 or Sdh7. The stability of 35 S-Sdh2 as monitored during the chase phase of the reaction was compromised in cells lacking Sdh6 or Sdh7, especially in mitochondria isolated from stationary-phase cultures ( Figure 2B ). This result is consistent with the exacerbated defect in SDH activity seen in mutant cells at late stages of growth. Unlike Sdh2, radioisotope-labeled Rip1, a target of the LYR protein Mzm1, remained unaffected by loss of either Sdh6 or Sdh7. Sdh1 and Sdh2 accumulate in cells lacking the membrane anchor subunits Sdh3 and/or Sdh4 ( Figure S3A ) (Kim et al., 2012) . We observed that cells depleted of the membrane anchor contain increased steady-state levels of both Sdh6 and Sdh7 ( Figure 2C ). These results suggest that Sdh6 and Sdh7 may form stalled preassembly intermediates with Sdh1 and/or Sdh2. We performed coimmunoprecipitation on epitope-tagged Sdh6 and Sdh7 in mitochondria from WT cells and cells stalled in SDH assembly. A fraction of Sdh1 and Sdh2 was copurified with either Sdh6 or Sdh7 from cells lacking the membrane anchor domain, but not in cells devoid of Sdh2 ( Figures 2D, 2E , and S3B). These interactions are seen in the presence and absence of crosslinking prior to resin adsorption. These results suggest that Sdh6 and Sdh7 interact with Sdh2 within a Sdh1/ Sdh2 subcomplex, which is known to accumulate in cells lacking the membrane anchor domain (Kim et al., 2012) . Moreover, these interactions appear to occur in the mitochondrial matrix, consistent with the known matrix location of Sdh1, Sdh2, and Sdh6 (Ghezzi et al., 2009) . Sdh7 is also a matrix protein, as revealed by proteinase K treatment of purified mitochondria, which degrades Sdh7 only in the presence of detergents and not upon hypotonic disruption of only the outer membrane.
( Figure S3C ).
The physical interactions of Sdh6 and Sdh7 with Sdh2 prompted the hypothesis that Sdh6 and Sdh7 may be chaperones for Sdh2. To test this, we first examined the ability of overexpressed Sdh6 or Sdh7 to stabilize the highly labile Sdh2 present in sdh1D cells (Kim et al., 2012) . Elevated levels of Sdh6, but not Sdh7, led to increased steady-state Sdh2 levels under these conditions ( Figure 2F ). This result raised a possibility that Sdh6 may function as a chaperone for Sdh2 prior to its interaction with Sdh1. We tested whether SDH2 overexpression in sdh6D mutants or sdh7D mutants would restore SDH activity and suppress the respiratory growth defects. However, SDH2 overexpression neither restored SDH activity nor reversed succinate accumulation or rescued respiratory growth of sdh6D mutants and sdh7D mutants ( Figures 2G, 2H , S4A, and S4B).
Once a holo-Sdh2/Sdh1 complex forms, the final step in SDH biogenesis is the addition of the Sdh3/Sdh4 membrane anchor. To address whether Sdh6 and Sdh7 are involved in the recruitment of the membrane anchor, we tested whether co-overexpression of SDH3 and SDH4 would suppress the respiratory defect in the sdh6D and sdh7D mutant cells. No restoration of growth on acetate medium was observed with elevated cellular levels of Sdh3 and Sdh4 ( Figures S4C and S4D ). Thus, Sdh6 and Sdh7 do not likely facilitate the recruitment of the Sdh3/ Sdh4 membrane anchor.
We conducted a series of studies to assess whether Sdh6 or Sdh7 has an active role in FeS cluster insertion. These studies failed to reveal a direct role of either factor in FeS cluster insertion. First, affinity purification of Sdh2 in yeast leads to copurification of Nfu1, Isu1, and Isa2, three key matrix proteins involved in FeS biogenesis (data not shown). However, affinity purification of Sdh6-His 6 -2Myc or Sdh7-His 6 -2Myc failed to adsorb Isu1 or Isa2, whereas Sdh2 was associated. Second, whereas overexpression of ISA1 or ISA2 restores respiratory growth in grx5D (C) Sdh6-His 6 -3HA or Sdh7-His 6 -3HA under their own endogenous promoters was expressed from plasmids in cells lacking either Sdh2 or Sdh4, along with endogenous Sdh6 or Sdh7 depleted, respectively. Steady-state levels are shown by immunoblotting. (D) Coimmunoprecipitation of Sdh6-His 6 -2Myc after crosslinking. Mitochondria were solubilized with 1% digitonin in the presence of 1 mM dithiobis(succinimidylpropionate). The crosslinking reaction was stopped with Tris buffer (pH 7.4), and the supernatants were absorbed to anti-Myc antibody-conjugated magnetic beads. Bound substances to Myc beads were resolved on SDS-PAGE and detected by immunoblotting. Input, 4% of total lysates; Aco1, FeS aconitase. (E) Standard coimmunoprecipitation of Sdh7-His 6 -2Myc was performed with isolated mitochondria without crosslinking. Input, 2% of total lysates. (F) Steady-state levels of Sdh2 in sdh1D mutants with overexpression of proteins indicated. Yap1, transcription factor upregulating oxidative stress response genes. (G) SDH activity in sdh6D mutants with SDH2 overexpression was detected as described in Figure 1E . Data are represented as mean ± SD (n = 3; **p < 0.05; ns, not significant).
(H) Succinate levels in sdh7D mutants with SDH2 overexpression were measured as described in Figure 1D . Mean ± SEM is shown (n = 6; **p < 0.05; ns, not significant). See also Figure S3 . mutant cells (Kim et al., 2010; Rodríguez-Manzaneque et al., 2002) (B) Serial dilutions (10-fold) of cells were spotted on SC medium with the indicated carbon sources with or without 5 mM N-acetylcysteine or 2 mM glutathione and incubated at 30 C.
(C) Succinate levels in cells overexpressing YAP1 were measured as described in Figure 1D . Cells were harvested at OD 600 = 1. Mean ± SEM is shown (n = 6; *p < 0.005).
Antioxidants Ameliorate Defects in sdh6D Mutants and sdh7D Mutants Further clues to the function of Sdh6 emerged from a genetic suppressor study in which extragenic suppressors of the acetate growth defect of sdh6D mutants were recovered. We generated a high-copy plasmid library with partially digested genomic DNA from sdh6D mutants. This library was transformed to sdh6D mutants, and the transformants that exhibited enhanced growth on acetate medium were collected. Interestingly, multiple independent suppressors were recovered that encoded Yap1, which is a transcriptional activator that induces the expression of a battery of antioxidant genes, including thioredoxin, thioredoxin reductase, and glutathione reductase, in response to oxidative stress (Fernandes et al., 1997) . The overexpression of YAP1 in subcloned vectors robustly suppressed the acetate growth defect of cells lacking Sdh6 ( Figure 3A) . Consistent with the antioxidant role of Yap1 expression, supplemental glutathione or N-acetylcysteine also restored limited respiratory growth in sdh6D mutants ( Figure 3B ). Since we observed a genetic interaction between SDH6 and SDH7 (Figure 1) , we tested whether overexpression of YAP1 could also restore respiratory growth in sdh7D mutants. Indeed, YAP1 overexpression suppressed the respiratory growth defect of sdh7D mutants, although the suppression was less pronounced compared to sdh6D mutants ( Figure 3A) . Moreover, the addition of exogenous reductants restored limited respiratory growth of sdh7D mutants ( Figure 3B ). To confirm that YAP1 overexpression restored SDH activity in sdh6D and sdh7D singlemutant cells, we assessed SDH activity by measuring succinate levels using metabolomics. Indeed, YAP1 overexpression decreased succinate levels in both sdh6D and sdh7D mutants significantly, while YAP1 overexpression did not affect succinate levels in sdh2D mutants as a negative control ( Figure 3C ). Therefore, we conclude that YAP1 overexpression contributes to the restoration of SDH activity in sdh6D and sdh7D mutants. Elevated levels of Yap1, however, have no effect on the respiratory growth defects in sdh6D sdh7D double mutants ( Figure 3A ).
Sdh2 Is Stabilized by Sdh6 and Sdh7 under Oxidative Stress Conditions
We hypothesized that Sdh6 and Sdh7 may be important for SDH maturation under oxidative stress conditions. Initially, we tested whether cells lacking Sdh6 or Sdh7 were hypersensitive to the superoxide anion generator paraquat. The respiratory growth defect of sdh6D and sdh7D single mutants was dramatically exacerbated in the presence of paraquat ( Figure 4A ). Likewise, steady-state levels of Sdh2 were markedly attenuated in paraquat-treated sdh6D and sdh7D mutants compared to WT cells ( Figure 4B ). In contrast, steady-state levels of other mitochondrial FeS containing proteins were not significantly altered by paraquat in the mutant cells ( Figure 4B ).
The paraquat sensitivity of sdh6D and sdh7D mutants may arise from either enhanced ROS damage or the accumulation of a pro-oxidant in the mutants. We observed that ROS levels were not changed in untreated sdh6D and sdh7D mutants using two different assays. First, we quantified aconitase (Aco1) activity. The 4Fe-4S cluster in aconitase is susceptible to ROS damage (Gardner, 2002) ; thus, aconitase activity is an indicator of ROS stress in vivo. No diminution of aconitase activity was seen in sdh6D and sdh7D mutants compared to WT ( Figure 4C ). Second, we tested the mutant cells for hydrogen peroxide sensitivity on rich glucose medium. As cells accumulate ROS, they become sensitized to exogenous ROS and subsequently lose viability (Khalimonchuk et al., 2007) . After 2 hour treatment of cells with 6 mM H 2 O 2 , the viability of sdh2D, sdh3D, and sdh4D mutant strains was significantly compromised ( Figure 4D ). However, sdh6D and sdh7D mutant cells exhibited no growth defects. The lack of impairment in aconitase activity and hydrogen peroxidase sensitivity suggest that ROS levels are not elevated in sdh6D and sdh7D mutants as compared to WT cells. It is notable that sdh1D and sdh5D single mutants and the sdh4D sdh5D double mutant did not show hydrogen peroxide sensitivity compared to sdh2D, sdh3D, and sdh4D strains, which suggests that an assembly intermediate containing FAD-Sdh1 may be the source for electron leakage for the generation of ROS in sdh2D, sdh3D, and sdh4D single mutants.
The observed hypersensitivity of sdh6D and sdh7D mutant cells to paraquat may imply that Sdh6 and Sdh7 are shielding the FeS clusters in Sdh2 prior to full assembly. Superoxide inactivation of the 4Fe-4S center in aconitase leads to a dissociation of one iron ion forming an inactive 3Fe-4S center that can be reactivated by supplemental iron salts (Gardner and Fridovich, 1992) . We tested whether supplemental iron salts would restore respiratory function to sdh6D and sdh7D mutant cells. Supplemental FeCl 2 , but not ZnCl 2 , restored limited glycerol growth to both mutant cells ( Figure 4E ). These data are consistent with a candidate role of Sdh6 and Sdh7 in FeS cluster protection in SDH maturation.
Drosophila Sdhaf3 Mutants Are Sensitive to Oxidative Stress
The Drosophila genome encodes a close ortholog of Sdh7 (Figure S5A ) but has only a weak candidate homolog of Sdh6. Accordingly, we examined the functions of Sdh7 in Drosophila to determine if its roles in SDH assembly and activity have been conserved through evolution and to define its possible physiological functions. Gene targeting was used to generate a null mutation in the Drosophila sdh7 ortholog (CG14898), which we refer to here as dSdhaf3 (Figures S5B and S5C) . These mutants were outcrossed for six generations to w 1118 , which was used as a control for most studies. dSdhaf3 mutants progress normally through development and have a normal lifespan when maintained on standard growth media. These animals are, however, sensitive to ethanol ( Figure 5A ) and oxidative stress, resulting from either paraquat treatment ( Figure 5B ) or hyperoxia ( Figure 5C ). The response to hyperoxia is most pronounced, with a 50% reduction in lifespan relative to controls, although SdhB 12081 hypomorphic mutants display a more severe effect (Walker et al., 2006) . Interestingly, most dSdhaf3 mutants exposed to 100% oxygen for 4 days held their wings erect, a hallmark of mitochondrial dysfunction and muscle degeneration (DeSimone et al., 1996; Greene et al., 2003) . A similar abnormal wing posture was observed in SdhB 12081 mutants maintained under normal conditions (10%-15%) or exposed to hyperoxia (80%-100%).
dSdhaf3 Mutants Display Reduced SdhB Protein Levels and SDH Activity
If the function of dSdhaf3 has been conserved through evolution, then dSdhaf3 mutants should display a specific defect in SDH function. Consistent with this possibility, metabolomic profiling of dSdhaf3 mutants revealed elevated succinate and reduced levels of fumarate and malate ( Figure 5D ). Biochemical analysis of mitochondrial extracts from dSdhaf3 mutants demonstrated that dSdhaf3 mutants have normal levels of SdhA, but significantly reduced levels of SdhB ( Figure 5E ), resulting in an approximate 50% reduction in SDH enzymatic activity (Figures 5F and 5G), similar to the phenotypes of sdh7D yeast. SdhA is also flavinylated normally in dSdhaf3 mutants, as expected (Figure S5E ). Combining the hypomorphic SdhB 12081 allele with the dSdhaf3 mutation resulted in a dramatic decrease in viability, demonstrating a strong genetic interaction, consistent with the reduced levels of SdhB in dSdhaf3 mutants and confirming the functional interaction between dSdhaf3 and SDH ( Figure S6A ). Interestingly, although dSdhaf3 mutants are fully viable and fertile, they display a clear age-dependent reduction in movement ( Figure 5H ). While mutants at 1 week of adult life show no difference in motility relative to controls, mutants display an approximately 50% reduction in movement by 2 weeks of age and a more severe motility defect at later stages ( Figure 5H ). Mutants are also significantly more sensitive to paralysis by 2 weeks of age, relative to controls ( Figure S5F ). Thus, like its counterpart in yeast, dSdhaf3 is required to maintain normal SDH levels and activity and proper wing muscle function and motility in Drosophila.
Antioxidant and Genetic Rescue of dSdhaf3 Mutants
Consistent with the ability of antioxidants to suppress the growth defects in sdh7D yeast mutants, either a dietary (N-acetylcysteine) or genetic (Sod2 expression) reduction in oxidative stress rescued the hyperoxia sensitivity of dSdhaf3 mutants ( Figures 6A and 6B) . Unlike the yeast studies, however, (legend continued on next page)
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Maturation of the FeS Subunit of SDH overexpression of the putative Sdh6 homolog (encoded by CG34229), using Act5C-GAL4 to drive a UAS-CG34229 transgene in dSdhaf3 mutants, had no effect on their sensitivity to hyperoxia ( Figure S6B ). This result, however, is difficult to interpret because there is only limited sequence homology between CG34229 and Sdh6. We conclude that this functional interaction between Sdh6 and Sdh7 may not be conserved through evolution or, alternatively, that CG34229 is not a functional homolog of Sdh6. The wing posture and motility defects in dSdhaf3 mutants suggested that these animals suffer from muscular and neuronal dysfunction. Consistent with this model, widespread expression of WT dSdhaf3 (Act > dSdhaf3) in dSdhaf3 mutants fully rescues their sensitivity to hyperoxia ( Figure 6C ), while muscle-specific (C57 > dSdhaf3) or neuronal-specific (elav > dSdhaf3) expression provides partial rescue ( Figure 6D ). Similar effects are seen on the climbing defects in dSdhaf3 mutants ( Figures 6E and 6F ). Genetic rescue in the fat body (Cg-GAL4) or intestine (Mex-GAL4), however, provided no significant rescue (data not shown). Widespread overexpression of dSdhaf3 in wild-type flies has no significant effect on their resistance to hyperoxia (data not shown). Taken together, we conclude that dSdhaf3 function is conserved through evolution and that proper SDH levels and activity are required for resistance to oxidative stress as well as muscular and neuronal function, consistent with their dependence on mitochondrial oxidative phosphorylation.
SDHB Is Specifically Impaired in Human Cells Deficient in Wild-Type SDHAF1
The human Sdh6 ortholog, SDHAF1, was shown previously to be important for SDH activity and abundance in fibroblasts (Ghezzi et al., 2009) ; however, its mechanism of action remained undefined. We addressed whether SDHAF1 protects SDHB (the human Sdh2 ortholog) from ROS damage similar to yeast Sdh6. First, we determined steady-state levels of SDH structural subunits in SDHAF1-depleted human embryonic kidney 293 (HEK293) cells by siRNA knockdown. SDHB and SDHC levels were significantly reduced upon SDHAF1 depletion ( Figure 7A ). SDHA levels, however, remained unaffected. Next, we tested the effects of paraquat on SDHAF1-depleted HEK293 cells. In accordance with the yeast and fly data, SDHB levels were further attenuated in SDHAF1-deficient cells ( Figure 7B ). The sensitivity to paraquat also suggests that SDHAF1 resembles Sdh6 in protecting holo-SDHB from ROS damage.
We also examined the steady-state SDHB levels in patient fibroblasts with a known SDHAF1 mutation . Both SDHB and SDHC levels were diminished in mitochondria isolated from the patient fibroblasts, whereas SDHA levels remained unaffected compared to controls ( Figure 7C ). SDHB protein levels were <50% of wild-type controls, and SDH enzyme activity was 52% and 40% in patients 1 and 2 relative to control values. Thus, the limited SDHB levels in the patient cells likely contribute to reduced SDH function.
DISCUSSION
The present work demonstrates that maturation of the FeS subunit of Sdh2 (SDHB) requires the participation of two assembly factors, Sdh6 (SDHAF1) and Sdh7 (SDHAF3). These factors are shown to guide Sdh2 maturation within the mitochondrial matrix in the midst of endogenous oxidants. Yeast, flies, and mammalian cells lacking one of these factors are impaired in SDH activity and assembly, with Sdh2 exhibiting a heightened susceptibility to oxidants. Normal oxidative metabolism in the mitochondria leads to the formation of superoxide anions from the one-electron reduction of O 2 . Superoxide anions can readily dissociate FeS clusters, rendering the assembly of FeS cluster centers in mitochondrial enzymes susceptible to oxidative damage. The present studies in yeast, flies, and mammalian cells suggest that Sdh6 and Sdh7 shield one or more of the three FeS clusters in Sdh2 from oxidants during assembly.
Yeast studies reveal that Sdh6 and Sdh7 act in concert in the maturation of Sdh2 with a limited redundancy in function. Yeast lacking either factor show a marked SDH deficiency in late-log cultures that rely on oxidative metabolism. Under these conditions, the mutant cells contain a reduced level of the assembled tetrameric enzyme. These cells exhibit a hypersensitivity to the superoxide generator paraquat. The respiratory defect of these mutants is readily suppressed by overexpression of the Yap1 transcriptional activator of oxidative stress genes or exogenous reductants. These studies highlight the role of Sdh6 and Sdh7 in shielding Sdh2 maturation from deleterious effects of oxidants.
Flies lacking the Sdh7 ortholog SDHAF3, likewise, are hypersensitive to paraquat and hyperoxia. The mutant flies show diminished levels of active SDH and, as a result, accumulate succinate. The dSdhaf3 mutants are viable and fertile yet display impaired movement that intensifies with age. The erect wing phenotype exhibited under hyperoxic conditions and the motility defects evident in aged mutant flies are consistent with muscular and neuronal dysfunction. Moreover, neuronal or muscle-specific expression of wild-type dSdhaf3 is sufficient to partially rescue the hyperoxia sensitivity of the mutants, demonstrating the importance of SDH function in these tissues that rely heavily on oxidative phosphorylation (OXPHOS). The hyperoxia sensitivity of dSdhaf3 mutants is also partially suppressed by dietary N-acetylcysteine or overexpression of the matrix manganosuperoxide dismutase Sod2. These effects of antioxidants mimic the rescue of yeast sdh7D mutant oxidative growth and demonstrate the apparent close conservation of Sdh7/SDHAF3 function through evolution.
Conservation in Sdh6/SDHAF1 function between yeast and humans also exists. Attenuation of SDHAF1 in HEK293 culture cells leads to a hypersensitivity in the stability of the FeS SDHB subunit to paraquat. SDHB instability is also seen in two SDHAF1 patient fibroblast lines. One implication of the observed antioxidant rescue of the defect of sdh6D yeast cells and dSdhaf3 mutant flies is the potential use of antioxidant therapeutics for patients afflicted with SDHAF1 (and perhaps SDHAF3) (D) Precultures grown up to late-log phase in YPD media were diluted 2-fold, followed by addition of 6 mM H 2 O 2 and incubated for 2 hr at 30 C. Cells were washed with sterile water, and 10-fold serial dilutions were spotted on YPD plate, followed by incubation at 30 C.
(E) Enhanced respiratory growths of sdh6D mutants and sdh7D mutants with iron supplementation. Serial dilutions (10-fold) of cells were spotted on SC media with or without FeCl 2 or ZnCl 2 with the indicated concentrations and then incubated at 30 C. mutations. Patients with SDHAF1 mutations have presented with SDH-deficient leukoencephalopathy (Ghezzi et al., 2009; Ohlenbusch et al., 2012) and have a survival window that may be amenable to antioxidant therapy. Two case studies were reported that attempted to alleviate clinical symptoms in SDHdeficient patients harboring SDHAF1 mutations by supplementing riboflavin and CoQ10. The clinical outcomes, however, were not significantly improved (Jain-Ghai et al., 2013) . More recently, a candidate therapeutic, EPI-743, is being tested for treatment of Leigh syndrome patients (Martinelli et al., 2012) . EPI-743 is a vitamin E quinone that is orally bioavailable and crosses the blood-brain barrier (Shrader et al., 2011) . Future studies will focus on the efficacy of antioxidants with SDHAF1 patient fibroblasts. In addition, it is important to note that every gene encoding an SDH subunit or known assembly factor is causally associated with human disease. We thus anticipate that SDHAF3 mutations will be associated with one or more previously idiopathic SDH-associated diseases and propose that SDHAF1 and SDHAF3 are candidate susceptibility factors for undefined SDH-deficient tumors.
The present work provides insights into the physiological function of Sdh6 and Sdh7 in Sdh2 maturation. Sdh6 and Sdh7 are shown to bind to the Sdh1/Sdh2 assembly intermediate that accumulates in mutants lacking the SDH membrane anchor. In addition, both Sdh6 and Sdh7 accumulate in the membrane anchor mutant cells. Sdh6 was found to impart stabilization to Sdh2 in cells lacking the FAD subunit Sdh1, suggesting that at least Sdh6 has a specific interface for Sdh2. These assembly factors do not appear to be apo-Sdh2 chaperones, since elevated levels of Sdh2 do not suppress the respiratory defects of sdh6D or (F) A continuous colorimetric assay was used to measure SDH enzyme activity in extracts of purified mitochondria from w 1118 controls, dSdhaf3 mutants, and UAS-dSdhaf3/+ transformants. ***p < 0.001. (G) Proteins from purified mitochondria were extracted from w 1118 controls and dSdhaf3 mutants, fractionated by nondenaturing PAGE, and analyzed for SDH and complex IV activity.
(H) Control w 1118 flies and dSdhaf3 mutants were tested for motility in three independent experiments using a total of 18 vials with 20 adults/vial at 1, 2, 3, or 4 weeks of age. Climbing ability is reported as the number of flies that climbed above a line drawn 4 cm above the bottom of the vial 5 s after being tapped to the bottom. *p < 0.05; ***p < 0. (B) Expression of Sod2 using the ubiquitous Act5C-GAL4 driver (Act>Sod2; purple line) partially rescues the hyperoxia sensitivity of dSdhaf3 mutants. Both NAC treatment and Sod2 expression significantly rescue the hyperoxia sensitivity of dSdhaf3 mutants; p < 0.001. (C) Expression of wild-type dSdhaf3 using the ubiquitous Act5C-GAL4 driver (Act>dSdhaf3; purple line) rescues the hyperoxia sensitivity of dSdhaf3 mutants (p < 0.001).
(D) The muscle-specific C57-GAL4 driver provides minor, but significant (p < 0.01), rescue of the hyperoxia sensitivity of dSdhaf3 mutants (purple line) relative to the control that carries the UASdSdhaf3 transgene alone (green line), while the CNS-specific elav-GAL4 driver provides more efficient rescue (orange line) (p < 0.001).
(E and F) Expression of wild-type dSdhaf3 by using either (E) the ubiquitous Act5C-GAL4 driver (purple), (F) the muscle-specific C57-GAL4 driver (purple), or (F) the CNS-specific elav-GAL4 driver ( orange) rescues the climbing defect in dSdhaf3 mutants. The Act>dSdhaf3 rescue in (C) and (E) was performed in females, and other rescue studies were performed in males (A, B, D, and F). The apparent partial rescue of dSdhaf3 mutants by a single copy of the UAS-dSdhaf3 transgene (C and D, green line) appears to be due to genetic background since UAS-dSdhaf3 transformants have normal levels of SdhB and SDH activity (E and F). Each graph was compiled from two experiments with a total of 10 vials with 20 animals per vial. ***p < 0.001. 
Cell Metabolism
Maturation of the FeS Subunit of SDH sdh7D mutants. Sdh6 and Sdh7 appear to be key chaperones in holo-Sdh2 maturation during oxidative growth. However, a recent report implicated SDHAF1 in an active role in FeS cluster insertion (Maio et al., 2014) . The observation that the two LYR proteins Sdh6 and Sdh7 function with the FeS cluster Sdh2 subunit has significant implications for the uncharacterized LYR proteins present in the human proteome. Our studies raise the possibility that future functional studies of LYRM1, LYRM2, LYRM5, and LYRM9 will reveal roles in maturation of mammalian-specific FeS cluster enzymes.
EXPERIMENTAL PROCEDURES Yeast Strains and Plasmids
All S. cerevisiae strains and plasmids used are listed in Tables S1 and S2, respectively. Culture media and conditions are described in detail in the Supplemental Experimental Procedures.
Mitochondrial Enzymatic Activity Assay
Succinate dehydrogenase (SDH) and aconitase activity assays were performed as described previously (Atkinson et al., 2011) . For SDH activity, quinone-mediated reduction of dichlorophenolindophenol (DCPIP) upon succinate oxidation was measured with isolated mitochondria spectrophotometrically at 600 nm. Aconitase activity was measured with 100 mM cis-aconitate in 50 mM Tris (pH 7.4) at 240 nm in soluble fractions of mitochondria disrupted by repetitive freeze-thaw. For malate dehydrogenase (MDH) activity, soluble mitochondrial fractions were obtained using sonication. Oxidation of 0.2 mM NADH was monitored in the presence of 2 mM oxaloacetate in 100 mM Tris (pH 7.4) at 340 nm (Hayes et al., 1991) .
Mitochondrial Protein Import Assay
Mitochondrial protein import assay was performed as described previously (Wagener et al., 2011) . Briefly, SDH2 and RIP1 open reading frames were subcloned in pGEM-4Z for in vitro transcription and translation, respectively. Radiolabeled precursor proteins were obtained using reticulocyte lysate (Promega) in the presence of 35 S-Met. Precursors were imported into 75 mg of isolated mitochondria in 50 mM HEPES-KOH (pH 7.2) buffer containing 0.6 M sorbitol, 0.5 mg/ml BSA, 2 mM potassium phosphate, 75 mM KCl, 10 mM magnesium acetate, 2 mM EDTA, 2.5 mM MnCl 2 , 2 mM ATP, 2 mM NADH, 10 mM creatine phosphate, 0.1 mg/ml creatine kinase, 2.5 mM malate, and 2.5 mM succinate for 30 min at 25 C for pulse. Import was stopped by adding 5 mM valinomycin and then chased for the periods of time indicated. Nonimported precursors were degraded by proteinase K on ice. Samples were separated on SDS-PAGE and detected by autoradiography.
Coimmunoprecipitation
Mitochondria were solubilized in 10 mM sodium phosphate (pH 7.4), 500 mM NaCl, 1 mM EDTA, 1% digitonin, and 13 protease inhibitor cocktail (Roche) for 30 min on ice. Crosslinking was performed with solubilization by adding 1 mM of dithiobis(succinimidylpropionate) (Pierce) for 30 min at room temperature (RT). After centrifugation at 14,000 3 g, supernatants were incubated with magnetic anti-Myc beads (Cell Signaling Technology) for 4 hr at 4 C. Beads were washed with 10 mM sodium phosphate (pH 7.4), 500 mM NaCl, 1 mM EDTA, 0.1% digitonin, and 1 mM PMSF. After washing three times, bound substances were recovered by boiling with 23 SDS-PAGE sample buffer, which was subjected to immunoblotting.
Drosophila Strains
Flies were maintained on standard Bloomington Stock Center medium with malt at 25 C. The following stocks were obtained from the Bloomington Stock Center: SdhA HP21216 /CyO (Bloomington #22087), SdhB 12081 /CyO (Walker et al., 2006) , da-Gal4 (Wodarz et al., 1995) , and Act5C-Gal4/CyO (Bloomington #25374). The UAS-dSdhaf3 transformants were generated as described in the Supplemental Experimental Procedures.
Statistics
Yeast data were analyzed using Microsoft Excel 2011. Data are presented as mean ± SD or mean ± SEM, as indicated. Statistical significance was evaluated using Student's t test. p < 0.05 was considered significant. Statistical analysis and graphical presentation for Drosophila studies were performed using PRISM software. Student's t test was used for pairwise comparisons, and one-way ANOVA was used for multiple comparisons. Fly metabolomic data are graphically represented as box plots, with the box representing the lower and upper quartiles, the horizontal line representing the median, and the bars representing the minimum and maximum data points. All other data are shown as the mean ± SEM. 
